Difference between revisions of "Uterine carcinosarcoma"

Jump to navigation Jump to search
(→‎General: rework)
Line 73: Line 73:
*[http://path.upmc.edu/cases/case227.html MMMT - case 1 - several images (upmc.edu)].
*[http://path.upmc.edu/cases/case227.html MMMT - case 1 - several images (upmc.edu)].
*[http://path.upmc.edu/cases/case328.html MMMT - case 2 - several images (upmc.edu)].
*[http://path.upmc.edu/cases/case328.html MMMT - case 2 - several images (upmc.edu)].
==IHC==
Features:
*CD10 +ve/-ve (16 +ve of 27<ref name=pmid21161468>{{Cite journal  | last1 = Koivisto-Korander | first1 = R. | last2 = Butzow | first2 = R. | last3 = Koivisto | first3 = AM. | last4 = Leminen | first4 = A. | title = Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers. | journal = Tumour Biol | volume = 32 | issue = 3 | pages = 451-9 | month = Jun | year = 2011 | doi = 10.1007/s13277-010-0138-1 | PMID = 21161468 }}</ref>).
*SMA  -ve/+ve (11 +ve of 27<ref name=pmid21161468/>).
*Desmin -ve/+ve (9 +ve of 27<ref name=pmid21161468/>).


==See also==
==See also==
48,466

edits

Navigation menu